BioHemp International

BioHemp International Provides Update on Current Status and its CBD Business Model

  NEW YORK, Oct. 24, 2019  -- – BioHemp International, Inc. (OTC: BKIT), (“Company”), a Company focused on consolidating distributors in the CBD industry, provides update on its current status, and outline of its future business model. The Company is pleased to announce it has retained two law firms to begin the process of bringing the company back to 'current' tier status with OTC Markets and the Securities and Exchange Commission (SEC). The Company is working diligently to provide all...

read more

BioHemp International, Inc. (OTC: BKIT) Acts in Response to SEC and OTC Trading Suspension

NEW YORK, New York--August 9, 2019 – – As previously disclosed on July 26th, 2019, the Securities and Exchange Commission ("Commission") announced the temporary suspension, pursuant to Section 12(k) of the Securities Exchange Act of 1934 (the "Exchange Act"), of trading in the securities (the “Trading Suspension”) of BioHemp International (“BioHemp”) (OTC: BKIT) of New York, NY at 9:30 a.m. EDT on July 26, 2019, and terminating at 11:59 p.m. on August 8th, 2019.  BKIT is currently...

read more


Mcap MediaWire - Costumer Service

Translate »